Oxcarbazepine-structure (Oxcarbazepine 150mg 300mg 600mg Tab For Sun 1)
Oxcarbazepine
Product Images NDC 33261-842
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 33261-842). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Oxcarbazepine-fig1 (Oxcarbazepine 150mg 300mg 600mg Tab For Sun 2)
This appears to be a table with two columns indicating the treatment group and the Exit rate. The first row of the table seems to indicate the timing of the treatment, while the second row marks the start of the data collection starting from Day 2 to Day 11. Without more context, it is difficult to provide a more detailed description.*
Oxcarbazepine-fig2 (Oxcarbazepine 150mg 300mg 600mg Tab For Sun 3)
This appears to be a graph showing the exit rate based on time for a high treatment group. The y-axis displays the percentage of exit rate ranging from 0 to 100, while the x-axis shows the time to exit in days ranging from 0 to 130. The data points from day 1 to day 10 have a higher exit rate, and this is confirmed by the p-value of 0.0001 obtained from the log-rank test. There is also a legend that shows the treatment group as "HIGH".*
Oxcarbazepine-fig3 (Oxcarbazepine 150mg 300mg 600mg Tab For Sun 4)
The text appears to be a graph showing the exit rate over time for a treatment group labeled "HIGH". The graph includes 11 time intervals labeled from 0-10 and the corresponding exit rates in percentage. A log-rank test was conducted and resulted in a p-value of 0.0001. The graph displays time on the x-axis in days and exit rate on the y-axis.*
Oxcarbazepine-fig4 (Oxcarbazepine 150mg 300mg 600mg Tab For Sun 5)
Exit rate data is provided in a table format for two treatment groups distinguished as HIGH and Low. The table includes a graph with x-axis labeled Time to ext in days and y-axis is presented with Exit rate value ranges. However, the text also includes some errors and non-English characters making it difficult to understand the context completely.*
Image Label (Oxcarbazepine 150mg 300mg 600mg Tab For Sun 6)
This is a description of a medication package for Feegmans AIDAREX PHARMACEUTICALS LLC Oxcarbazepine 150mg. The package has 90 tablets with each tablet containing 150mg of Oxcarbazepine as the active ingredient. The tablets are coated with a film and have a score on the reverse. The package is generic for Trileptal RX GLS0000 %0. The manufacturer of the package is Sun Pharmaceutical Industries Ltd in Mumbai, India. The package has a prescription and should be stored in a controlled room temperature between 15-30C.*
Image Label (Oxcarbazepine 150mg 300mg 600mg Tab For Sun 7)
The text appears to be a description of a medication called oxcarbazepine, specifically a 300mg tablet. It may be a generic version of the brand name drug Trileptal. The tablet may need to be taken every few hours throughout the day. However, there are many errors in the text, and much of it is not recognizable as English.*
Image Label (Oxcarbazepine 150mg 300mg 600mg Tab For Sun 8)
This appears to be a description of a medication called Oxcarbazepine, 600mg strength, in a container with 60 tablets. The medication is produced by AIDAREX PHARMACEUTICALS LLC and is a generic version of Trileptal. The instructions indicate to take the medication every 12 hours, twice a day. The manufacturer appears to be PanmoEUTEAL WD, LTD MK.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
